Additional supporting information may be found in the online version of this article at the publisher's web-site.

bit25198-sm-0001-SupFig-S1.tif1716KFigure S1. Overview of the targeted engineering process.
bit25198-sm-0002-SupTable-SI.doc16KTable SI. Primers used in this study.
bit25198-sm-0003-SupTable-SII.doc15KTable SII. Plasmids 1 used in this study.
bit25198-sm-0004-SupTable-SIII.doc15KTable SIII. Protein concentrations used in the titration of the synergistic effects of two or more proteins.
bit25198-sm-0005-SupTable-SIV.doc30KTable SIV. MS parameters of peptides used in the targeted.
bit25198-sm-0006-SupTable-SV.doc14KTable SV. Codon optimized DNA sequence used in this study.
bit25198-sm-0007-SupData.docx51KSupporting Data 1
bit25198-sm-0008-SupData.doc128KSupporting Data 2

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.